# Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

> **NCT00941161** · PHASE4 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 28 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** metformin/glimepiride combination
- **DRUG:** metformin
- **DRUG:** glimepiride

## Key facts

- **NCT ID:** NCT00941161
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2010-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941161, "Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00941161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*